CAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cardinal Health Inc (CAH) is a good buy for a beginner investor with a long-term strategy and an investment range of $50,000-$100,000. The company demonstrates strong financial growth, positive analyst sentiment, and a stable business trajectory, making it a solid addition to a long-term portfolio.
The technical indicators show a neutral to slightly bearish short-term trend. The MACD is below zero and negatively contracting, while the RSI is at 35.101, indicating the stock is nearing oversold territory. The stock is trading near its support level of 205.472, with resistance at 212.623. This suggests a potential rebound opportunity for long-term investors.
Analysts have consistently raised price targets, with the highest target at $260, reflecting confidence in the company's growth trajectory.
Strong Q2 financial performance with 18.75% YoY revenue growth, 16.75% YoY net income growth, and 19.39% YoY EPS growth.
Strategic leadership changes and ongoing execution bolster investor confidence.
Jim Cramer's Charitable Trust increased its stake, signaling confidence in the stock.
Recent market decline (-1.71% regular market change) and broader SP500 drop (-1.79%) may weigh on short-term sentiment.
Lack of significant insider or hedge fund activity in recent months.
Cardinal Health reported strong Q2 fiscal 2026 results, with revenue increasing to $65.63 billion (up 18.75% YoY), net income rising to $467 million (up 16.75% YoY), and EPS increasing to $1.97 (up 19.39% YoY). Gross margin also improved to 3.52%, up 3.83% YoY, showcasing robust financial health and growth momentum.
Analysts maintain a highly positive outlook on Cardinal Health, with multiple firms raising price targets recently. The highest price target is $260, and the lowest is $233, with all ratings being 'Overweight,' 'Outperform,' or 'Buy.' Analysts cite strong performance across all business segments and consistent execution as key drivers of optimism.
